Recombinant pharmaceuticals from microbial cells: a 2015 update

Diabetes, growth or clotting disorders are among the spectrum of human diseases related to protein absence or malfunction. Since these pathologies cannot be yet regularly treated by gene therapy, the administration of functional proteins produced ex vivo is required. As both protein extraction from...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Garcia, Laura, Martín, Lucas, Mangues, Ramon, Ferrer-Miralles, Neus, Vázquez, Esther, Villaverde, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748523/
https://www.ncbi.nlm.nih.gov/pubmed/26861699
http://dx.doi.org/10.1186/s12934-016-0437-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748523/
https://www.ncbi.nlm.nih.gov/pubmed/26861699
http://dx.doi.org/10.1186/s12934-016-0437-3

Ejemplares similares